Description
Soy’s Second Act in Perimenopause explores how one of nutrition’s most debated foods has moved from early promise, through backlash, into a far more nuanced clinical role. This episode unpacks receptor selectivity, equol, bone preservation, vasomotor symptoms, and why SERMS such as isoflavones may matter most during a phase defined by instability. This is a fresh look at where soy genuinely earns its place in modern peri/menopause care.
